Aspirin inhibits human telomerase activation in unstable carotid plaques

Li,Fangming; Guo,Yi; Jiang,Xin; Zhong,Jianxin; Li,Guandong; Sun,Shenggang

doi:10.3892/etm.2013.1082

Aspirin inhibits human telomerase activation in unstable carotid plaques

Authors:
- Fangming Li
- Yi Guo
- Xin Jiang
- Jianxin Zhong
- Guandong Li
- Shenggang Sun
View Affiliations

Affiliations: Department of Neurology, Jiangmen Central Hospital, Jiangmen, Guangdong 529070, P.R. China, Department of Neurology, The Second Affiliated Hospital of Jinan University, Shenzhen, Guangdong 518020, P.R. China, Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China
Published online on: April 29, 2013 https://doi.org/10.3892/etm.2013.1082
Pages: 204-208

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The activation of telomerase in unstable plaques is an important factor in atherosclerosis, and may be predictive of the risk of cerebrovascular diseases. Human telomerase reverse transcriptase (hTERT) is a subunit of telomerase that is essential for telomerase activation. The aim of the present study was to investigate whether aspirin inhibits the activation of telomerase and hTERT in unstable carotid plaques. Polymorphonuclear neutrophils (PMNs) derived from carotid plaques were isolated from the washing medium of angioplasty balloons, while circulating PMNs, isolated from arterial blood, served as the controls. A polymerase chain reaction‑based telomeric repeat amplification protocol (TRAP) enzyme‑linked immunosorbent assay (ELISA) was used to measure the telomerase activity in the cells following treatment with aspirin. The mRNA and protein expression of hTERT were detected by a reverse transcription‑polymerase chain reaction (RT‑PCR) and western blot analysis, respectively. The results revealed that the atherosclerotic plaques were positive for telomerase activity, and that aspirin inhibited the telomerase activity of the PMNs derived from the plaques. In addition, aspirin was demonstrated to inhibit the mRNA and protein expression of hTERT through the suppression of hTERT transcriptional activity; however, it had no inhibitory effect on the telomerase activity of the circulating PMNs. Thus, the activation of telomerase in resident PMNs is critical in the instability of carotid plaques. The upregulation of telomerase and hTERT during the progression of atherosclerosis may indicate a role for telomerase in the vascular remodeling that occurs during atherogenesis. Aspirin was demonstrated to inhibit the activation of telomerase via an hTERT‑dependent manner in the PMN cells of unstable carotid plaques, and thus hTERT may be considered as a target in the treatment of cerebrovascular diseases.

View Figures

View References

1.	Samani NJ and van der Harst P: Biological ageing and cardiovascular disease. Heart. 94:537–539. 2008. View Article : Google Scholar : PubMed/NCBI
2.	Greider CW: Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA. 95:90–92. 1998. View Article : Google Scholar : PubMed/NCBI
3.	Le S, Sternglanz R and Greider CW: Identification of two RNA-binding proteins associated with human telomerase RNA. Mol Biol Cell. 11:999–1010. 2000. View Article : Google Scholar : PubMed/NCBI
4.	Bailey SM and Murnane JP: Telomeres, chromosome instability and cancer. Nucleic Acids Res. 34:2408–2417. 2006. View Article : Google Scholar : PubMed/NCBI
5.	Harley CB and Villeponteau B: Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev. 5:249–255. 1995. View Article : Google Scholar : PubMed/NCBI
6.	Shay JW and Wright WE: Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol. 1:72–76. 2000. View Article : Google Scholar : PubMed/NCBI
7.	Holt SE, Glinsky VV, Ivanova AB and Glinsky GV: Resistance to apoptosis in human cells conferred by telomerase function and telomere stability. Mol Carcinog. 25:241–248. 1999. View Article : Google Scholar : PubMed/NCBI
8.	Yang J, Chang E, Cherry AM, et al: Human endothelial cell life extension by telomerase expression. J Biol Chem. 274:26141–26148. 1999. View Article : Google Scholar : PubMed/NCBI
9.	Weinmann P, Gaehtgens P and Walzog B: Bcl-Xl- and Bax-alpha-mediated regulation of apoptosis of human neutrophils via caspase-3. Blood. 93:3106–3115. 1999.PubMed/NCBI
10.	Sung YH, Choi YS, Cheong C and Lee HW: The pleiotropy of telomerase against cell death. Mol Cells. 19:303–309. 2005.PubMed/NCBI
11.	Naruko T, Ueda M, Haze K, et al: Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 106:2894–2900. 2002. View Article : Google Scholar : PubMed/NCBI
12.	Husain S, Andrews NP, Mulcahy D, Panza JA and Quyyumi AA: Aspirin improves endothelial dysfunction in atherosclerosis. Circulation. 97:716–720. 1998. View Article : Google Scholar : PubMed/NCBI
13.	Cyrus T, Yao Y, Tung LX and Praticò D: Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin. Atherosclerosis. 184:8–14. 2006. View Article : Google Scholar : PubMed/NCBI
14.	Biasucci LM, Liuzzo G, Grillo RL, et al: Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation. 99:855–860. 1999. View Article : Google Scholar : PubMed/NCBI
15.	Narducci ML, Grasselli A, Biasucci LM, et al: High telomerase activity in neutrophils from unstable coronary plaques. J Am Coll Cardiol. 50:2369–2374. 2007. View Article : Google Scholar : PubMed/NCBI
16.	He H, Xia HH, Wang JD, et al: Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma. Cancer. 106:1243–1249. 2006. View Article : Google Scholar : PubMed/NCBI
17.	Poch E, Carbonell P, Franco S, Díez-Juan A, Blasco MA and Andrés V: Short telomeres protect from diet-induced atherosclerosis in apolipoprotein E-null mice. FASEB J. 18:418–420. 2004.PubMed/NCBI
18.	Brouilette SW, Moore JS, McMahon AD, et al: Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet. 369:107–114. 2007. View Article : Google Scholar : PubMed/NCBI
19.	Gizard F, Heywood EB, Findeisen HM, et al: Telomerase activation in atherosclerosis and induction of telomerase reverse transcriptase expression by inflammatory stimuli in macrophages. Arterioscler Thromb Vasc Biol. 31:245–252. 2011. View Article : Google Scholar : PubMed/NCBI
20.	Ducrest AL, Szutorisz H, Lingner J and Nabholz M: Regulation of the human telomerase reverse transcriptase gene. Oncogene. 21:541–552. 2002. View Article : Google Scholar : PubMed/NCBI
21.	Hiyama K, Hirai Y, Kyoizumi S, et al: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol. 155:3711–3715. 1995.PubMed/NCBI
22.	Robertson JD, Gale RE, Wynn RF, Dougal M, Linch DC, Testa NG and Chopra R: Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns. Br J Haematol. 109:272–279. 2000. View Article : Google Scholar : PubMed/NCBI
23.	Norrback KF, Enblad G, Erlanson M, Sundström C and Roos G: Telomerase activity in Hodgkin's disease. Blood. 92:566–573. 1998.
24.	Kim NW, Piatyszek MA, Prowse KR, et al: Specific association of human telomerase activity with immortal cells and cancer. Science. 266:2011–2015. 1994. View Article : Google Scholar : PubMed/NCBI
25.	Wong JM and Collins K: Telomere maintenance and disease. Lancet. 362:983–988. 2003. View Article : Google Scholar : PubMed/NCBI
26.	Bodnar AG, Oulette M, Frolkis M, et al: Extension of life-span by introduction of telomerase into normal human cells. Science. 279:349–352. 1998. View Article : Google Scholar : PubMed/NCBI
27.	Satyanarayana A, Manns MP and Rudolph KL: Telomeres, telomerase and cancer: an endless search to target the ends. Cell Cycle. 3:1138–1150. 2004. View Article : Google Scholar : PubMed/NCBI
28.	Zimmerman S and Martens UM: Telomeres and telomerase as targets for cancer therapy. Cell Mol Life Sci. 64:906–921. 2007. View Article : Google Scholar : PubMed/NCBI
29.	Kang SS, Kwon T, Kwon DY and Do SI: Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem. 274:13085–13090. 1999. View Article : Google Scholar
30.	Li H, Zhao L, Yang Z, Funder JW and Liu JP: Telomerase is controlled by protein kinase Cα in human breast cancer cells. J Biol Chem. 273:33436–33442. 1998.PubMed/NCBI